Variable | NLR ≥ 4.19 (n = 30) | NLR < 4.19 (n = 152) | P Value |
---|---|---|---|
Demographics | |||
Age, years | 62.97 ± 13.43 | 58.98 ± 12.54 | 0.118 |
Male, sex, n (%) | 17 (56.7) | 71 (46.7) | 0.319 |
Chronic comorbidities | |||
HTN, n (%) | 9 (30.0) | 33 (21.7) | 0.325 |
DM, n (%) | 2 (6.7) | 11 (7.2) | 0.912 |
COPD, n (%) | 1 (3.3) | 1 (7.0) | 0.744 |
CAD, n (%) | 1 (3.3) | 1 (7.0) | 0.744 |
Clinical manifestations | |||
Fever, n (%) | 29 (96.7) | 150 (98.7) | 0.993 |
Vomiting, n (%) | 8 (26.7) | 28 (18.4) | 0.300 |
Diarrhea, n (%) | 5 (16.7) | 42 (27.6) | 0.210 |
Headache, n (%) | 10 (33.3) | 52 (34.2) | 0.926 |
Abdominal pain, n (%) | 2 (6.7) | 16 (10.5) | 0.755 |
Cough, n (%) | 7 (23.3) | 23 (15.1) | 0.269 |
Lymphadenopathy, n (%) | 12 (40.0) | 56 (36.8) | 0.744 |
Petechiae, n (%) | 7 (23.3) | 21 (13.8) | 0.187 |
GCS scores, mean ± SD | 11.76 ± 3.26 | 13.59 ± 2.43 | 0.006 |
Laboratory parameters | |||
RDW, mean ± SD, % | 13.23 ± 0.93 | 13.28 ± 1.22 | 0.840 |
PLT count, median (IQR), ×109/L | 55.00 (36.00, 88.50) | 48.50 (34.00, 77.50) | 0.327 |
PT, mean ± SD, s | 12.35 ± 2.73 | 11.30 ± 1.06 | 0.059 |
APTT, mean ± SD, s | 43.07 ± 15.66 | 39.81 ± 12.57 | 0.121 |
ALT, median (IQR), U/L | 62.00 (36.98, 87.60) | 73.30 (47.30, 123.50) | 0.093 |
AST, median (IQR), U/L | 98.75 (73.90, 220.63) | 132.60 (71.7, 262.90) | 0.534 |
LDH, median (IQR), U/L | 755.00 (548.25, 1417.25) | 747.50 (399.5,1282.25) | 0.668 |
TBil, median (IQR), μmol/L | 10.00 (6.65, 24.45) | 10.00 (6.90,16.40) | 0.425 |
DBil, median (IQR), μmol/L | 4.45 (2.43, 10.78) | 4.20 (2.50, 6.05) | 0.243 |
SCr, mean ± SD, μmol/L | 80.72 ± 65.32 | 62.31 ± 35.75 | 0.144 |
BUN, median (IQR), mmol/L | 4.70 (3.85,6.30) | 3.50 (2.70, 4.90) | 0.002 |
Complications | |||
MODS, n (%) | 16 (53.3) | 35 (23.0) | 0.001 |
Duration of hospital | |||
Length of hospital stay, median (IQR) days | |||
Outcome | 7.00 (5.75, 12.00) | 9.50 (7.00, 12.00) | 0.047 |
28-day mortality, n (%) | 13 (43.3) | 11 (7.2) | 0.001 |